For the year ending 2025-12-31, IMMX has $104,840,341 in assets. $11,044,171 in debts. $93,928,566 in cash and cash equivalents.
| Balance Sheets | 2025-12-31 | |||
|---|---|---|---|---|
| Cash and cash equivalents | 93,928,566 | |||
| Short-term investments | 6,480,860 | |||
| Prepaid expenses and other current assets | 828,329 | |||
| Total current assets | 101,237,755 | |||
| Other assets | 20,418 | |||
| Deferred offering costs | 93,630 | |||
| Right-of-use asset, net | 966,917 | |||
| Property and equipment, net | 2,521,621 | |||
| Total assets | 104,840,341 | |||
| Accounts payable and accrued expenses | 9,971,207 | |||
| Operating lease liabilities - current | 139,339 | |||
| Total current liabilities | 10,110,546 | |||
| Operating lease liabilities - long term | 933,625 | |||
| Total liabilities | 11,044,171 | |||
| Common stock, 0.0001 par value 200,000,000 shares authorized 53,023,466 shares issued and 52,951,103 shares outstanding at december 31, 2025, and 27,612,383 shares issued and 27,540,020 shares outstanding at december 31, 2024 | 5,301 | |||
| Additional paid-in capital | 198,293,956 | |||
| Accumulated other comprehensive income | 60,160 | |||
| Accumulated deficit | -104,463,284 | |||
| Treasury stock at cost, 72,363 shares as of december 31, 2025, and 2024 | 99,963 | |||
| Total stockholders equity | 93,796,170 | |||
| Total liabilities and stockholders equity | 104,840,341 | |||
Immix Biopharma, Inc. (IMMX)
Immix Biopharma, Inc. (IMMX)